Knightscope (NASDAQ: KSCP) is pursuing a bigger prize than selling robots: it is assembling an integrated, technology-enabled security service designed to combine autonomous machines, AI software, remote monitoring and licensed human agents under one accountable operating model.
There is no shortage of…
Serina Therapeutics, Inc. (NYSE American: SER) is building a potentially compelling clinical and platform-driven story around a familiar biotech proposition: take a medicine with demonstrated utility, improve the way it behaves in the body, and create a product patients may find meaningfully…
Knightscope, Inc. (NASDAQ: KSCP) is making a broader case than “robots on patrol.” With record second-quarter revenue, an expanding national client base, new AI-driven security capabilities and an integrated model that joins autonomous machines with trained human professionals, the company is positioning itself…
NVIDIA Corp. (NASDAQ: NVDA) has spent the past several years selling the shovels for the artificial-intelligence gold rush. Its planned $12.93 billion acquisition of Hugging Face suggests it now wants a more influential place in the mine, the marketplace and perhaps the…
AGNT, Inc. (NASDAQ: AGNT) has added another data point to its agent-attraction narrative: Fresno-based Tafoya Real Estate, a 37-agent California mega team with $87.92 million in sales volume across 172 transaction sides in 2024 and 2025, has moved to eXp Realty from…
FMC Corporation (NYSE: FMC) heads into the 2026 Jefferies Global Industrials Conference with a story that is no longer about simply enduring a difficult crop-protection cycle. It is increasingly about balance-sheet repair, portfolio renewal and the possibility that a battered agricultural-sciences franchise is…
Yatsen Holding Limited (NYSE: YSG) is approaching a consequential earnings date with a more compelling narrative than the market may be pricing in: a China beauty platform shifting from online color-cosmetics challenger to science-led, premium omnichannel operator. Its partnership to place Perfect Diary…
The biotechnology market has a habit of demanding patience right up until it abruptly decides to reward it. Moderna, Inc. (NASDAQ: MRNA) recently reminded investors of that rule as enthusiasm around its personalized melanoma-vaccine program with Merck & Co., Inc. (NYSE: MRK)…
For patients with eosinophilic esophagitis, eating can become an exercise in calculated risk rather than a simple pleasure. For Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), that burden represents both an urgent medical problem and a potentially compelling opportunity to prove that…
FIGS, Inc. (NYSE: FIGS) just delivered the kind of quarter that reminds investors why “boring” healthcare can quietly become a growth stock thriller—no meme magic required, just rising margins, disciplined execution, and a growing global tribe of loyal customers.
Healthcare Couture Gets…
